epithelial ovarian cancer

This topic is about epithelial ovarian cancer, the most common type.

These are a kind of epithelial ovarian cancer, the most common kind.

Genetic risk and screening techniques for epithelial ovarian cancer.

Intraperitoneal chemotherapy for women with epithelial ovarian cancer.

Before age 30 years, the risk of developing epithelial ovarian cancer is remote; even in hereditary cancer families.

Invasive epithelial ovarian cancers in white women.

Epithelial ovarian cancer in black women.

They reviewed the medical records of 216 patients at Cedars-Sinai who had surgery for epithelial ovarian cancer.

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.

The pathogenesis of epithelial ovarian cancer.

A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer.

In general, all patients with malignant germ cell tumors will have the same staging surgery that is done for epithelial ovarian cancer.

Most cancers of the ovary come from the cells that make up the outer lining, and are called epithelial ovarian cancers.

The scientists then tracked the incidence of invasive epithelial ovarian cancer using the Swedish national cancer and death registries.

Kaye SB: Bevacizumab for the treatment of epithelial ovarian cancer: will this be its finest hour?

Therefore, extracellular S1P could have an important role in cancer progression by promoting migration of epithelial ovarian cancer cells.

Prognosis and treatment is the same as for the most common type of ovarian cancer, which is epithelial ovarian cancer.

Hoskins WJ: Surgical staging and cytoreductive surgery of epithelial ovarian cancer.

Tumors of low malignant potential (i.e., borderline tumors) account for 15% of all epithelial ovarian cancers.

Hogg R, Friedlander M: Biology of epithelial ovarian cancer: implications for screening women at high genetic risk.

Jaaback K, Johnson N: Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

It has completed phase II human clinical trials against adenocarcinoma of the kidney, advanced epithelial ovarian cancer, and metastatic breast cancer.

Laboratory studies have shown anti-neoplastic effects of fungal extracts or isolated compounds against some types of cancer, including epithelial ovarian cancer.

Amos CI, Struewing JP: Genetic epidemiology of epithelial ovarian cancer.

Surprisingly, epithelial ovarian cancer and primary peritoneal cancer are histologically similar to the Mullerian epithelium; not their embryonal origin, the mesonephros.